Outcome of Two Different Suture Methods for Achilles Tendon Rupture

February 19, 2013 updated by: Peifu Tang

Closed Achilles Tendon Rupture Treats by Two Different Suture Methods and the Outcome

The purpose of this study is to estimate the effective of two suture methods in the treatment of Achilles rupture.

Study Overview

Detailed Description

Achilles tendon rupture is one of the most common tendon injuries in the adult population. The incidence of this injury is increasing as aging adults continue their participation in high-demand sports. Although the impact of an Achilles tendon rupture is substantial, often resulting in prolonged disability and rehabilitation. Studies have showed that the operation treatment of acute Achilles tendon ruptures had some advantages. But the rebuild of blood supply was not involved in previous studies. And the epitenon of tendon is the interior layer, closest to the endotenons which contains the vascular supply. Main difference of two suture methods were if the epitenon was repaired and sewed indirectly or unrepaired and sewed directly.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100853
        • Recruiting
        • Orthopedics department; The General Hospital of the People's Liberation Army
        • Contact:
        • Principal Investigator:
          • Zhang L Hai, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult men or women between 18 and 60 years of age.
  • Closed rupture confirmed with ultrasound or magnetic resonance imaging (MRI).
  • Operative within 14 days after injury.
  • Willing and able to comply with and carry out the prescribed rehabilitation protocol.
  • Providing informed consent.
  • No other major trauma.

Exclusion Criteria:

  • Refuse to participate.
  • Refuse to participate.
  • Additional ipsilateral injury.
  • Open injury.
  • Patients not suitable for surgery (i.e., mellitus diabetes, immunocompromised states, obesity (BMI.30), peripheral vascular disease or local/systemic dermatologic disorders) or have other surgical contraindications.
  • Fluoroquinolone-associated rupture (i.e., rupture within 2 weeks after taking this medication).
  • Achilles avulsion from the calcaneus or with bone fracture.
  • Neurological or vascular disease requiring medications recognized to impair tendon healing.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Indirectly
The epitenon was repaired and sewed indirectly.
The epitenon was repaired and sewed indirectly.
Placebo Comparator: Directly
The epitenon was unrepaired and sewed directly.
The epitenon was unrepaired and sewed directly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood supply condition
Time Frame: six weeks
Blood supply was estimated by ultrasonic contrast at six weeks after surgery.
six weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Calf circumference
Time Frame: six weeks
Calf circumference was measured at six weeks after surgery.
six weeks
Complications
Time Frame: six months
Infection and rerupture at six month after surgery.
six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Tang P Fu, Chinese PLA General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Anticipated)

May 1, 2013

Study Completion (Anticipated)

June 1, 2013

Study Registration Dates

First Submitted

June 5, 2012

First Submitted That Met QC Criteria

June 14, 2012

First Posted (Estimate)

June 19, 2012

Study Record Updates

Last Update Posted (Estimate)

February 20, 2013

Last Update Submitted That Met QC Criteria

February 19, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PLAGH OD 13

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendon Rupture

3
Subscribe